Publications by authors named "Marie Levy"
Article Synopsis
- BRAF V600 wild-type advanced melanomas have limited treatment options after immunotherapy fails, but trametinib, a MEK inhibitor, is one possible option.
- In a study of 22 patients, 36% had some control of their disease after using trametinib, but it mostly lasted only a couple of months.
- Many patients experienced side effects like skin rashes and tiredness, so doctors and patients should carefully consider this treatment together.
